Results 101 to 110 of about 4,279 (197)
Global & Regional Health Technology AssessmentIntroduction: The therapeutic approach to the patient with acute bacterial skin and skin structure infection (ABSSSI) and complicated infections often involves the early transition from intravenous to oral therapy (early switch) or early discharge.
Daniela Segala +10 more
doaj +1 more source
, 2018 Chronic osteomyelitis is a multifaceted bacterial infection with common features. It absolutely requires surgery for remission. The duration and form of concomitant administration of antibiotic agents for adult patients is still based on expert opinion ...
Gamulin, Axel +5 more
core
Mergers and acquisitions as strategies of business expansion in the pharmaceutical industry [PDF]
, 2012 Introduction: The present paper deals with the issue of the increasing usage of corporation mergers and acquisitions strategies within pharmaceutical industry environment.
Boboia, Anamaria, Condrat, Maria
core
Pharmacophore modelling as useful tool in the lead compounds identification and optimization [PDF]
, 2012 The goal of computer-aided molecular design methods in modern medicinal chemistry is to reduce the overall cost and time associated to the discovery and development of a new drug by identifying the most promising candidates to focus the experimental ...
ALMERICO, Anna Maria +4 more
core
Single-Dose Oritavancin Compared to Standard of Care IV Antibiotics for Acute Bacterial Skin and Skin Structure Infection in the Outpatient Setting: A Retrospective Real-World Study [PDF]
, 2017 Patrick J. Anastasio +3 more
core +1 more source
Pharmacokinetics, Safety, and Tolerability of a Single 500-mg or 1000-mg Intravenous Dose of Dalbavancin in Healthy Japanese Subjects [PDF]
, 2015 Mark Yen +4 more
core +1 more source
Dalbavancin: a novel antimicrobial.
International journal of clinical practice, 2007 The increasing incidence of serious infections because of Gram-positive pathogens and the rising cost in parenteral administration of antimicrobials has inspired the development of a novel antibiotic. Dalbavancin is the first once a week antibiotic with activity against a broad range of Gram-positive pathogens.
Chen, A Y, Zervos, M J, Vazquez, J A
openaire +2 more sources
Population Pharmacokinetics and Pharmacodynamics of Dalbavancin and C-Reactive Protein in Patients with Staphylococcal Osteoarticular Infections [PDF]
Background and objective: Dalbavancin is increasingly used for the long-term treatment of chronic osteoarticular infections. A population pharmacokinetic/pharmacodynamic (PK/PD) analysis for assessing the relationship between dalbavancin exposure and C ...
Cojutti, Pier Giorgio +4 more
core +1 more source
Journal of Global Antimicrobial ResistanceObjectives: To retrospectively describe the patterns of use of dalbavancin for treating infections in diabetic patients in Italian and Spanish standard clinical practice.
Laura Morata Ruiz +14 more
doaj +1 more source